Oslo, December 3, 2024 - Observe Medicals ("the Company" or "Observe Medical")
distributor in Italy has placed their first orders on UnoMeterT SafetiT Plus.

Italy has historically been among the top 5 countries in the global sales of
UnoMetersT with a 2021 net sales level of more than 19 mill. NOK. The portfolio
sold in Italy now consist of the whole UnoMeterT family consisting of UnoMeterT
500 UnoMeterT Abdo-PressureT and UnoMeterT SafetiT Plus.

Jørgen Mann, CEO of Observe Medical, commented, "With the inclusion of the
significant Italian market in the launch the UnoMeterT SafetiT Plus launch we
are now actively expanding in markets that represents approximately 55% of the
historic UnoMeterT sales. First order is a trial order intended to confirm to
the users that the product is the same as they have known for many years, which
we are confident it will".

For further information, please contact:

Jørgen Mann, CEO Observe Medical
Mobile: +45 408 67 558
E-mail: jorgen.mann@observemedical.com

Johan Fagerli, CFO Observe Medical
Mobile: +47 958 12 765
E-mail: johan.fagerli@observemedical.com

About Observe Medical

Observe Medical is a Nordic medtech company that develops, markets and sells
innovative medtech products for the global market. The Company is committed to
improving patient welfare and patient outcomes, improving clinical data accuracy
and promoting positive health economics.

The Company seeks to drive growth by leveraging its expertise in sales and
commercialization of its broad portfolio of medical technology products, mainly
in urine measurement and ultrasound, in combination with targeted M&A and
distribution. Observe Medical is working with a network of leading distributors
to provide outstanding solutions for healthcare professionals globally.

The Company is headquartered in Oslo, Norway.

Further information is available at www.observemedical.com.